NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

15-H-0017

Sponsoring Institute

National Heart, Lung and Blood Institute (NHLBI)

Recruitment Detail

Type: Completed Study; data analyses ongoing
Gender: Male & Female
Min Age: 18 Years
Max Age: 100 Years

Referral Letter Required

No

Population Exclusion(s)

Children

Keywords

Idiopathic Pulmonary Fibrosis;
Apoliprotein A-1;
Natural History

Recruitment Keyword(s)

None

Condition(s)

Idiopathic Pulmonary Fibrosis

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Heart, Lung, and Blood Institute

Background:

- Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that becomes worse over time. There is currently no effective treatment for it. Researchers want to study the disease and learn new ways to treat it.

Objectives:

- To discover new pathways that are involved in pulmonary fibrosis. To develop new drugs that may be used to treat pulmonary fibrosis.

Eligibility:

- People at least 18 years old with IPF.

- Healthy volunteers at least 18 years old.

Design:

- Participants will be screened with medical history, questionnaire, and physical exam. They will have blood, lung, and walking tests and chest scans.

- All participants will have 1 study visit, including:

- Medical history and physical exam.

- Questions about their breathing.

- Blood tests.

- Breathing tests.

- Six-minute walk test.

- Pregnancy test.

- Chest x-ray (healthy volunteers) or chest CT scan (people with pulmonary fibrosis ).

- Small area of skin may be removed.

- Genetic tests of blood and skin samples. Participants will probably not be informed of any findings. Samples may be used to make stem cells for use in research. Participants may be contacted in the future to give consent for this research.

- Some participants will have repeat visits over many years, repeating many of the study tests.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Patient:

Males and females over the age of 18 with a diagnosis of IPF.

EXCLUSION CRITERIA:

Patient:

Female subjects who are pregnant or lactating

INCLUSION CRITERIA:

Normal Volunteer:

Males and females over the age of 18 without IPF.

EXCLUSION CRITERIA:

Normal Volunteer:

Female subjects who are pregnant or lactating


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Stewart J. Levine, M.D.
National Heart, Lung and Blood Institute (NHLBI)
NIHBC 10 - CLINICAL CENTER BG RM 6D08
10 CENTER DR
BETHESDA MD 20892
(301) 402-1553
levines@nhlbi.nih.gov

Joni Y. Mills, C.R.N.P.
National Heart, Lung and Blood Institute (NHLBI)
NIHBC 10 - CLINICAL CENTER BG RM 6D03
10 CENTER DR
BETHESDA MD 20892
(301) 402-6623
joni.mills@nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: TTY Users Dial 7-1-1
ccopr@nih.gov

Clinical Trials Number:

NCT02315586

--Back to Top--